These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20669601)

  • 1. Lapse and relapse following inpatient treatment of opiate dependence.
    Smyth BP; Barry J; Keenan E; Ducray K
    Ir Med J; 2010 Jun; 103(6):176-9. PubMed ID: 20669601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illicit methadone use and abuse in young people accessing treatment for opiate dependence.
    Roche A; McCabe S; Smyth BP
    Eur Addict Res; 2008; 14(4):219-25. PubMed ID: 18679031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aftercare attendance and post-treatment functioning of severely substance dependent residential treatment clients.
    Sannibale C; Hurkett P; van den Bossche E; O'Connor D; Zador D; Capus C; Gregory K; McKenzie M
    Drug Alcohol Rev; 2003 Jun; 22(2):181-90. PubMed ID: 12850905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on short-term therapeutic effect and its impact factors of stereotactic surgery for treating opiate users with opiate dependence in Sichuan].
    Zhang B; Liao J; Wang ZR; Chen Y; Gu JW; Chen LG; Fang J
    Wei Sheng Yan Jiu; 2006 Sep; 35(5):599-603. PubMed ID: 17086714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
    Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol usage and associated treatment outcomes for opiate users entering treatment in Ireland.
    Stapleton RD; Comiskey CM
    Drug Alcohol Depend; 2010 Feb; 107(1):56-61. PubMed ID: 19819650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the outcome of inpatient opiate detoxification treatment: results from a multicenter study.
    Specka M; Buchholz A; Kuhlmann T; Rist F; Scherbaum N
    Eur Addict Res; 2011; 17(4):178-84. PubMed ID: 21494045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program.
    Almario CV; Seligman NS; Dysart KC; Berghella V; Baxter JK
    Am J Obstet Gynecol; 2009 Sep; 201(3):326.e1-6. PubMed ID: 19631928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.